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Background: Cystic fibrosis (CF) lung disease leads to progressive deterioration in exercise capacity. Because physical activity has been shown to
improve lung function and quality of life (QoL), developing routine exercise programs can benefit this patient population.
Methods: Lung function, nutritional status, and exercise capacity and assessments of habitual activity and QoL were measured before and after a
two-month, subject-designed exercise regimen based on self-reported activity assessment. Statistical analysis included Wilcoxon signed-rank,
Wilcoxon rank sum, and Fisher's exact tests.
Results: Subjects completing the study demonstrated significant improvement in exercise capacity and body image perception, a CF-specific QoL
measure (pb0.001). In secondary analyses, subjects improving exercise capacity showed significant increases in lung function and self-reported
habitual activity.
Conclusions: Increases in exercise capacity over a two-month period resulted in significantly improved lung function and self-reported habitual
activity. Longer, controlled trials are needed to develop individualized exercise recommendations.
© 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Exercise; Lung function; Quality of life; Habitual activity; Cystic fibrosis1. Introduction
Cystic fibrosis (CF) lung disease leads to progressive
deterioration in lung function and exercise capacity. Recent
studies have demonstrated the benefits of exercise for CF
patients [1,2] and include: slowing lung function decline [3] and
enhancing airway clearance [4,5]. More importantly, higher
exercise capacity has been associated with improved survival
[6]. The additional benefits of exercise for CF patients do not
differ from those for healthy individuals and include improved
conditioning and endurance, bone density, muscle strength,Abbreviations: BMI, body mass index; CF, cystic fibrosis; FEV1, forced expir
modified shuttle walk test; QoL, quality of life.
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doi:10.1016/j.jcf.2011.08.003posture and quality of life [7]. Moreover, exercise as a
therapeutic tool is underutilized [8]. There are many barriers
to exercise and physical activity in CF patients, including low
lung function, malnutrition, and cardiorespiratory decondition-
ing, as well as emotional barriers relating to the burden of care
in chronic disease [9,10].
In light of these barriers and the demonstrated benefit of
exercise for CF patients, efforts are being made to incorporate
exercise into routine care. While both hospital-based conditioning
programs and home-based programs have been shown to be
beneficial [11], the latter may present more opportunities toatory volume in 1 second; HAES, habitual activity estimation scale; MSWT,
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other caregivers. Furthermore, tomaximize the long-termbenefits,
any exercise program must be sustainable with a primary goal to
modify behaviors toward achieving amore active lifestyle. Home-
based programs have been shown to offer long-lasting benefits for
physical fitness, activity and lung function in CF patients more
than a year after the completion of the intervention [12]. The
purpose of this study was to determine if specific, subject-driven
exercise recommendations can improve selected outcomes in CF
patients with the hypothesis that increasing activity in CF patients
with a two-month exercise regimen leads to improved exercise
capacity, lung function, nutritional status, and quality of life.2. Patients and methods
2.1. Subjects
For this study approved by the Johns Hopkins University
Institutional Review Board, pediatric subjects with CF were
recruited at routine clinic visits after obtaining written informed
assent and consent from the patients and their parents or
guardians. Inclusion criteria were a confirmed diagnosis of CF,
an age of 6-16y, no concurrent IV antibiotic treatment and the
ability to perform exercise. Subjects were excluded if spirometry
demonstrated more than 10% decline in lung function (measured
by percent predicted FEV1) compared to the previous clinic visit
or required treatment with oral or intravenous antibiotics for a
pulmonary exacerbation. Seventy-eight subjects consented to
participate in the study; however, two did not perform the
Modified Shuttle Walk Test (MSWT) [13,14] at the first study
visit, six subjects withdrew voluntarily because they did not keep
up with the recommended exercise regimen and five subjects did
not complete the second study visit within the allotted follow-up
window. Of the sixty-five subjects who completed both study
visits, data from six of these subjects were not used because of
illness or minor unrelated injury at the time of the second study
visit.2.2. Study design
Exercise capacity was assessed before and after a two-month,
at-home exercise regimen. The study consisted of two clinical
visits. At the first study visit, exercise capacity was assessed using
a field test and two surveys were conducted to evaluate habitual
activity and quality of life. Routine spirometric and anthropo-
metric data were obtained. Based on an assessment of self-
reported activity, the two-month exercise regimen consisted of
activities chosen by the subject and was designed in conjunction
with the clinic physical therapist. Participants were encouraged
but not required to keep an exercise log. After one month,
adherence to the exercise regimen and habitual activity was
assessed by telephone. After two months, at the second study
visit, subjects repeated the exercise capacity field test and the
habitual activity and quality of life surveys with assessment of
adherence.2.3. Exercise capacity assessment
Exercise capacity was assessed using the MSWT [14]. The
MSWT is a validated field test of exercise capacity in pediatric
CF patients in which the participant walks 10 m lengths at
progressively increasing paces [13]. The number of completed
shuttles was recorded and used to express exercise capacity.
2.4. Habitual activity
Each subject's self-reported activity was assessed using the
Habitual Activity Estimation Scale (HAES), which has been
determined to be a valid and reliable instrument in the pediatric
and adult CF patient populations [15,16]. For this study,
habitual activity was expressed as the percentage of time when
the study subject was awake and engaged in moderate-vigorous
activity and recorded for a typical weekday and weekend.
2.5. Quality of life
The Revised CF Quality of Life Questionnaire (CFQ-R) was
administered to assess the subject's quality of life. The CFQ-R
is a validated instrument for CF patients that scores quality of
life in twelve general and CF-specific domains [17–19]. This
study focused on five exercise-related domains: physical
functioning, emotional functioning, social functioning, body
image perception, and respiratory wellness. Scores for each
domain were expressed on a scale of 0–100.
2.6. Exercise intervention
At visit 1, the physical therapist recommended an individ-
ualized, two-month, at home exercise regimen consisting of
regular, developmentally appropriate, and where applicable,
family-oriented physical activities. The regimen consisted of
20–30 minutes of moderate to vigorous activity at least five
times a week. The duration and intensity of the activity was
based on the patient's self-reported activity on the HAES. For
example, subjects who rated themselves overall as “inactive”
were given 20 minutes of moderate activity, while those who
reported themselves as “very active” were given 30 minutes of
vigorous activity. The types of activity were chosen by the study
subject in consultation with the physical therapist and included
a wide variety of sports, play, and physical extracurricular
activities. Emphasis was made to make the activities continuous
for the recommended duration. Subjects left the study visit with
a written copy of the exercise recommendation.
2.7. Statistical considerations
Demographic and clinical characteristics were summarized
using medians and ranges or frequencies and percentages.
Change from baseline at the two-month follow-up was
calculated for the clinical characteristics and quality of life
measures, and Wilcoxon signed-rank tests were used to test for
significant improvement. Subgroup analyses comparing boys to
girls and comparing those that improved by at least 10 shuttles
Table 2
Medians (ranges) of clinical and quality of life measures at baseline and follow-
up for the 59 subjects that completed the study.
Characteristic Baseline 2-Month Follow-up P value a
BMI, % for age 59 (2–96) 56 (2 – 93) 0.43
FEV1, % predicted
b 100 (52–132) 104 (41 – 130) 0.50
HAES
Weekday activity 56.7 (6.0 – 93.7) 50.1 (14.8 – 89.8) 0.40
Weekend activity c 63.0 (4.4 – 92.3) 67.3 (12.2 – 97.8) 0.17
Number of shuttles 100 (21 – 150) 105 (44 – 150) b0.001
CFQ-R scores
Physical 94.4 (27.8 – 100) 94.4 (44.4 – 100) 0.11
Emotional 75.0 (20.8 – 100) 79.2 (33.3 – 100) 0.06
Social 71.4 (33.3 – 100) 72.2 (28.6 – 100) 0.53
Body image 88.9 (11.1 – 100) 100 (0 – 100) b0.001
Respiratory 83.3 (33.3 – 100) 91.7 (25 – 100) 0.10
a P value from Wilcoxon signed-rank test.
b One subject did not have FEV1 data.
c Two subjects did not have HAES weekend activity data at follow-up.
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Wilcoxon rank sum tests for continuous measures and Fisher's
exact tests for categorical measures. Analysis was performed
using SAS version 9.2 (SAS Institute, Inc., Cary, NC). All
reported P values are two-sided, and significance was set at
pb0.05.
3. Results
3.1. Demographics
Baseline demographic and clinical characteristics of the 78
subjects are presented in Table 1. Overall, subjects showed
normal lung function (median FEV1 99% predicted) and
optimal nutritional status (median BMI percentile-for-age 56).
The subject sample included patients with severe lung disease
and growth failure. Self-reported activity was significantly
higher on typical weekends than on weekdays (median 63.2%
vs. 55.7%; p=0.004). Median baseline scores for five exercise-
related QoL measures ranged from 71.4-90.3.
3.2. Effects of a two-month exercise regimen
Baseline and two-month follow up data for the 59 subjects
who completed the study are summarized in Table 2. Exercise
capacity measured by the MSWT increased from 100 to 105
shuttles (pb0.001). At the two-month follow up visit, changes
in nutritional status, measured by BMI percentile, and lung
function, measured by percent predicted FEV1, were not
statistically significant. Self reported activity, using the
HAES, demonstrated that weekend habitual activity increased
but was not statistically significant. Of the five exercise-related
QoL measures assessed using the CFQ-R, physical functioning
did not change over the two-month period, while body image
perception, a CF-specific measure, showed a significant
increase from baseline (pb0.001). Emotional functioning,
social functioning, and respiratory wellness showed increases
that were not statistically significant over the two-month period.Table 1
Baseline demographic and clinical characteristics of the 78 patients a enrolled in
the study.
Characteristic No. of Patients (%) Median (range)
Gender, female 33 (42)
Age, in years 10 (6 – 16)
BMI, % for age 56 (2 – 96)
FEV1, % predicted 99 (32 – 132)
HAES
Weekday activity 55.7 (6.0 – 93.7)
Weekend activity 63.2 (0.0 – 95.8)
Number of shuttles 100 (20 – 150)
CFQ-R scores
Physical 90.3 (27.8 – 100)
Emotional 79.7 (20.8 – 100)
Social 71.4 (33.3 – 100)
Body image 88.9 (0 – 100)
Respiratory 83.3 (33.3 – 100)
a Two patients did not complete the baseline visit and only contribute gender
and age data, and one patient was unable to perform pulmonary function tests.Thirteen subjects did not complete the study; of these, 77%
were girls compared to 35% of those who did complete the
study (p=0.01). At baseline, self-reported activity was higher
and physical functioning and respiratory wellness scores by
QoL assessment were lower in the non-completers compared to
the completers, but these differences were not statistically
significant. The non-completers had comparable nutritional
status, lung function and exercise capacity to the completers.3.3. Relationship of exercise capacity to lung function and habitual
activity
To assess the utility of the MSWT as an instrument to measure
exercise capacity in the clinical setting and define clinically relevant
changes, the change from baseline in clinical and QoL measures
was analyzed with respect to improvement in exercise capacity
measured by the number of completedMSWTshuttles (Table 3). In
this secondary analysis, patients were stratified by an improvement
of at least 10 shuttles on the MSWT, which corresponds to a
distance walked of 100 m. Because the MSWT has a defined
maximum of 150 shuttles, three subjects who had completed at
least 140 shuttles during the initial visit were excluded from this
analysis. Of the 56 subjects included, 30 improved by at least 10
shuttles (median increase of 16 shuttles) and 26 did not improve by
at least 10 shuttles (median change of −1 shuttle). Both FEV1 and
the number of shuttles performed at baseline were comparable for
the group that improved by at least 10 shuttles and those that did not
(median: FEV1 at baseline: 99 vs. 102; p=0.16, shuttles at baseline:
97 vs. 100; p=0.63, respectively). Fifty percent of the subjects
whose exercise capacity did not improve by at least 10 shuttleswere
girls, compared to twenty percent of subjects whose exercise
capacity improved by at least 10 shuttles (p=0.02). Subjects that
improved exercise capacity showed significant increases compared
to subjects that did not in median percent predicted FEV1 (6% vs.
-3%, p=0.03) as well as in self-reportedweekend activity (5.9% vs.
-1.4%, p=0.03). Between the two groups, there was no difference
in change inBMI percentile for age and differences in changes from
Table 3
Demographic characteristics and change from baseline in clinical and quality of
life measures by improvement in number of shuttles for completers that
didb140 shuttles at baseline. Medians (ranges) are presented unless otherwise
stated.
Characteristic Change in Shuttles
b 10 ≥ 10 P value a
No. of patients 26 30
Female gender, N (%) 13 (50) 6 (20) 0.02
Age, years 10 (6 – 15) 10.5 (6 – 16) 0.20
BMI, % for age 1.5 (−13 – 21) 1.5 (−28 – 12) 0.61
FEV1, % predicted −3 (−18 – 10) b 6 (−16 – 37) 0.03
HAES
Weekday activity −7.0 (−62.5 – 26.3) 1.4 (−38.3 – 36.5) 0.08
Weekend activity −1.4 (−56.6 – 30.1) c 5.9 (−17.3 – 61.5) c 0.03
Number of shuttles −1 (−21 – 8) 16 (11 – 42)
CFQ-R scores
Physical 0.0 (−38.9 – 55.6) 0.0 (−38.9 – 27.8) 0.91
Emotional 4.2 (−26.7 – 33.3) 0.0 (−13.3 – 20.8) 0.51
Social 0.0 (−33.3 – 28.6) −4.8 (−16.7 – 28.6) 0.30
Body image 0.0 (−55.6 – 55.6) 11.1 (−44.5 – 66.7) 0.56
Respiratory 0.0 (−16.7 – 41.7) 0.0 (−50.0 – 50.0) 0.75
a P value from Wilcoxon rank sum test or Fisher's exact test (gender).
b One patient in this group did not have FEV1 data.
c One patient in this group did not have HAES weekend activity data.
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statistically significant.
3.4. Comparison by gender in changes from baseline of
clinical and QoL measures
Of the 59 subjects who completed the study, 40 were boys and
19 were girls (Table 4). Boys showed a marginal improvement
from baseline in exercise capacity compared to girls (11 vs. 5;Table 4
Demographic characteristics and change from baseline in clinical and quality of
life measures by gender for completers. Medians (ranges) are presented unless
otherwise stated.
Characteristic Gender
Boys Girls P value a
No. of patients 40 19
Age, years 10 (6 – 16) 11 (6 – 15) 0.51
BMI, % for age −1 (−28 – 16) 2 (−14 – 21) 0.61
FEV1, % predicted 3 (−18 – 37) b −2 (−11 – 21) 0.16
HAES
Weekday activity −1.0 (−62.5 – 36.5) −1.3 (−39.6 – 29.5) 0.94
Weekend activity 0.9 (−56.6 – 61.5) c 3.2 (−46.1 – 41.8) c 0.79
Number of shuttles 11 (−21 – 42) 5 (−21 – 21) 0.06
CFQ-R scores
Physical 5.6 (−38.9 – 55.6) −5.6 (−27.8 – 11.1) b0.001
Emotional 0.0 (−13.3 – 20.8) 0.0 (−26.7 – 33.3) 0.51
Social −0.0 (−28.6 – 28.6) 0.0 (−33.3 – 28.6) 0.71
Body image 11.1 (−55.6 – 66.7) 0.0 (−0.0 – 44.4) 1.0
Respiratory 0.0 (−50.0 – 50.0) 0.0 (−38.9 – 33.3) 0.64
a P value from Wilcoxon rank sum test.
b One patient in this group did not have FEV1 data.
c One patient in this group did not have HAES weekend activity data.p=0.06). Differences in the changes from baseline in nutritional
status, lung function, and habitual activity were not statistically
significant between boys and girls. With respect to exercise-
related QoL measures, boys showed a positive change from
baseline in physical functioning that was highly significant (+5.6
vs. -5.6; pb0.001). Themedian changes frombaseline in the other
QoL measures for girls were unchanged.4. Discussion
The results of this study demonstrated that a patient-driven
outpatient exercise program significantly improves exercise
capacity in children with CF and indicate that exercise can and
should be incorporated into a care regimen geared toward
improving respiratory and general physical health. An exercise
regimen can improve certain exercise-relevant quality of life
measures as well as increase exercise capacity, which is
beneficial, based on the results of this study, in the short term.
Moreover, the use of three validated instruments, the HAES,
CFQ-R, and MSWT, illustrates their applicability for both
exercise assessment and prescription in a practical clinical setting.
Exercise testing and training have long been recognized as
important aspects of CF care that are underutilized and warrant
further study, preferably using randomized, controlled clinical
trials [11], with respect to specific recommendations toward the
development of practical and effective exercise training
programs in the CF population [20]. Both formal and field
tests of exercise are primarily limited by costs, equipment,
space, and time [21]. Exercise training and habitual physical
activity have been shown to be effective in children with CF and
to slow the rate of decline of FEV1, particularly in girls [10,16].
In a randomized controlled trial analyzing the long-term effects
of a partially supervised conditioning program in children and
adults with CF, the investigators concluded that a 6 month home
based partially supervised and individualized program led to
long-lasting beneficial effects on physical fitness, activity, and
lung function over a 1–2 year period, indicating that such
programs can result in changing behaviors toward physical
activity [12].
Certain CF-specific risks [20,22] associated with exercise
require careful consideration by patients, families, and care
providers, specifically with respect to design of a therapeutic
exercise program. These can include the potential risks of
prolonged exercise, such as dehydration, excessive salt loss,
bronchoconstriction, and hypoxemia. Other concerns include
the possibility of hypoglycemia in a patient with CF-related
diabetes or impaired glucose tolerance, or spontaneous fractures
in patients who may have unrecognized or untreated bone
disease or exhibit excessive cough during physical activity.
Additional exercise-related risks include pneumothorax, cardiac
arrhythmias, hemoptysis, and variceal bleeding [20]. Specific
precautions to avoid contact sports should be taken in patients
who have known portal hypertension and hepatosplenomegaly.
It should be mentioned that while the risk of serious adverse
reactions to exercise have not been systematically studied, the
incidence of exercise-related serious adverse reactions appears
22 S.M. Paranjape et al. / Journal of Cystic Fibrosis 11 (2012) 18–23to be low with respect to exercise testing, inpatient exercise
therapy, and independent exercise in the CF population [22].
Education of the CF care team regarding the advantages and
potential risks of exercise is vital to the success of designing
exercise programs for CF patients [10]. Consideration of
potential physical and psychosocial barriers to exercise in
conjunction with those related to the burden of chronic disease
can facilitate the implementation of exercise into the therapeutic
regimen toward improving compliance with habitual physical
activity as well as other components of the care regimen.
Moreover, using this information can enable CF care teams to
utilize exercise testing in a practical setting to further assess
lung function and overall physical health.
The major advantage of this study was the use of validated
instruments to assess exercise capacity and habitual activity
toward the design of an individualized exercise regimen and
track progress, particularly in exercise capacity and lung
function, over a two-month period. Given the strong correlation
between distance walked and peak oxygen consumption [23],
the MSWT is a valid measure of peak exercise performance that
can be used in a clinical setting. In our study, girls reported lower
habitual activity and had poorer lung function than boys, which
supports the conclusion of previously published studies [16].
Another striking and concerning finding was 68% of girls
completing the study did not improve exercise capacity over a 2-
month period. It is unclear if this lack of improvement was
related to disease severity or other factors, such as choice of
activity or extent of participation in activities and adherence to
the recommended exercise regimen. Based on these results, girls
may benefit from implementing routine exercise programs as
part of an overall regimen to maintain general health. The
collaborative aspects of this study utilized the expertise in
physical therapy and engaged the subject to design an exercise
program based on self-reported habitual physical activity. In
particular, choosing enjoyable activities and emphasizing family
participation may have promoted the incorporation of activity
into the daily life of the patient. The use of developmentally
appropriate, family-friendly, and enjoyable activities chosen by
the patient rather than concrete exercise plans prescribed by the
CF care team promotes both patient adherence and the long-term
incorporation of exercise into the lifestyle of the patient.
Study limitations include: small sample size, which limited
the power to detect significant results; the lack of a control
group to fully assess the effect of the intervention; selection bias
with respect to enrollment of healthy patients with normal lung
function and nutritional status; decreased capability to account
for overreporting on the HAES by the subject's parent due to
time constraints in the outpatient clinic; and adherence to the
prescribed exercise regimen. Some subjects reported limitations
of activity based on season, time of year, intercurrent illnesses
or minor unrelated injuries at the second study visit. Other
subjects did not complete the study because of the timing of the
second study visit, which was to take place earlier than the
routine clinic visit, and posed a scheduling conflict for families
with other constraints such as insurance authorizations for
routine clinic visits. The MSWT has been validated for pediatric
CF patients [13,23–25]. Nevertheless, the study results mayhave been influenced either by a training effect, in which subjects
may have improved exercise capacity because they learned to
perform the test [14], or a ceiling effect, in which subjects would
not have shown an improvement in exercise capacity above the
test-defined maximum of 150 completed shuttles. From the
clinician's perspective, other limitations include the ability to
encourage patients to maintain increased activity levels over time
in order to demonstrate whether the exercise program had a
sustained effect and determine howmuch of an increase in activity
is needed to achieve a beneficial response.
Despite these limitations, this study has demonstrated the
potential of theMSWT andHAES as objective clinical measures of
exercise tolerance and habitual activity, as well as the advantage of
an at-home exercise regimen to improve clinical outcomes.
Additionally, we found that testing and development of an exercise
plan could be carried out during routine clinic encounters. This
study utilized three validated instruments, the CFQ-R, HAES, and
MSWT, to clinically assess exercise capacity and use the data to
design individualized exercise programs for children with CF and
track their clinical progress. The results of this study showed that
regular exercise over a two-month period improved exercise
capacity and certain QoL measures, and that improvements in
exercise capacity improved lung function and habitual activity.
5. Conclusion
We conclude that a two-month, at-home exercise regimen is
beneficial for pediatric CF patients. The MSWT and the HAES
questionnaire have practical applications in the outpatient setting
for measuring exercise tolerance and habitual activity that are well
tolerated by the patients and easily implemented. Future studieswill
include a longer follow-up period in order to assess the
sustainability of the exercise regimen and long-term benefits and
applications to help patients adopt a healthy lifestyle. In addition, a
longer controlled trial is needed to determine if incorporating these
tools into clinical practice to standardize exercise assessment and
prescribing an individualized exercise regimen as an adjunct to
conventional therapies can lead to improved lung function and
quality of life.
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